PUNE, India, August 27, 2018 /PRNewswire/ --
The key players in the next-generation sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).
Browse 106 Market Data Tables and 44 Figures spread through 228 Pages and In-depth TOC on "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024" at https://www.reportsnreports.com/reports/508000-next-generation-sequencing-ngs-market-by-platforms-hiseq-miseq-hiseq-x-ten-x-five-nextseq500-ion-proton-pgm-ions5-pacbio-sequel-services-targeted-sequencing-de-novo-application-diagnostic-drug-discovery-global-forecasts-to-2021.html .
The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024from USD 5.70 billion in 2018, at a CAGR of 19.2%. The next-generation sequencing market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies.
Next-Generation Sequencing Market, By Application
3 Cancer Diagnostics
4 Infectious Disease Diagnostics
5 Reproductive Health Diagnostics
6 Diagnostic Applications
7 Drug Discovery
8 Agricultural & Animal Research
Next-Generation Sequencing Market, By End User
2 Academic Institutes & Research Centers
3 Hospitals & Clinics
4 Pharmaceutical & Biotechnology Companies
Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel growth of this market.
Order the "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024" Report Now at https://www.reportsnreports.com/purchase.aspx?name=508000 .
The next-generation sequencing market is segmented into pre-sequencing products & services (DNA fragmentation, end repair, A-tailing, and size selection; library preparation & target enrichment; and quality control), NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics (NGS data analysis, storage, and management).
Target Audience for this Report:
- Manufacturers and suppliers of vaccines
- Research and development companies
- Medical research laboratories
- Academic medical centers and universities
- Research and consulting firms
- Venture capital firms
The next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these, the academic institutes & research centers segment is expected to account for the largest share of the next-generation sequencing market in 2018.
Download the Sample Brochure of Global Next-Generation Sequencing (NGS) Market Research Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=508000 .
Report covers the next-generation sequencing market in North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), and the Rest of the World (RoW). North America is expected to account for the largest share of the global next-generation sequencing market in 2018, followed by Europe.
Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 36%
- By Designation: C-level - 43%, Director-level - 22%, and Others - 35%
- By Region: North America - 37%, Europe - 12%, APAC - 41%, and RoW -10%
Another research titled report studies global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics. The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). is available with discount now at https://www.reportsnreports.com/contacts/discount.aspx?name=288443 .
Explore More Reports on Medical Devices at https://www.reportsnreports.com/market-research/medical-devices/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Tower B5, office 101,
Hadapsar, Pune-411013, India
Connect with Us: